Media centre
Press releases and news
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Video gallery
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
CRISPR technology for genome editing
CRISPR, a pioneering genome-editing technique, technology will allow AstraZeneca to identify and validate new drug targets in preclinical models that closely resemble human disease.
Advancing the science of cancer diagnosis
Learn how we are advancing the science of cancer diagnosis, and making biopsies easier for patients, through the diagnosis of circulating tumour DNA in blood samples.
AstraZeneca, designs for new Cambridge site
AstraZeneca reveals designs for new Global R&D Centre and Corporate Headquarters in Cambridge, UK